Products

Overseer AI

AI-native

Making AI safer.

overseerai.app AI Models & Agents / Prompts, Evals & LLM Observability

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Max Sonderby
@overseeraix· 3 followers
Launched
22mo ago
2025-01-14 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
X accounts@overseeraix
  • Launched on Product HuntLaunch

    open-source LLM with safety & governance API

    Jan 23, 2025 · 22mo agoLaunch page

  • Launched on Product HuntLaunch

    Handle AI governance with a simple, custom-policy-driven API

    Jan 14, 2025 · 22mo agoLaunch page

MCP Server & Agent Ecosystem

GitHub · MCP / Skill

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct40%
  • Organic Search32%
  • Referrals10%
  • Social6%
  • Other11%

Countries

  • United States57%
  • Brazil43%

Search

Domain authority —Domain registered 2024-12-18

KeywordMonthly volume
overseer19.5K
overseeros1,030
overseer app600
overseerer390
ovrseer340

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2025-01-14

Key pages

Weekly snapshots
Home
overseerai.app/ Snapshot 2026-11-04

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Overseer AI get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Overseer AI and what platforms does it support?
Overseer AI is catalogued under Prompts, Evals & LLM Observability: Making AI safer.. Supported platforms: CLI / SDK.

Related products in this category

AI Models & Agents / Prompts, Evals & LLM Observability

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.